skip to main content

Content language

Contact us: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > ceramide > oligoglycosylceramide > glycohexaosylceramide > monosialyl-gb5(1-) > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > ceramide > oligoglycosylceramide > glycohexaosylceramide > monosialyl-gb5(1-) > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > organooxygen compound > sphingolipid > ceramide > oligoglycosylceramide > glycohexaosylceramide > monosialyl-gb5(1-) > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > ceramide > oligoglycosylceramide > glycohexaosylceramide > monosialyl-gb5(1-) > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > organooxygen compound > carboxamide > ceramide > oligoglycosylceramide > glycohexaosylceramide > monosialyl-gb5(1-) > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > ceramide > oligoglycosylceramide > glycohexaosylceramide > monosialyl-gb5(1-) > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > liposaccharide > glycolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > glycohexaosylceramide > monosialyl-gb5(1-) > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > glycohexaosylceramide > monosialyl-gb5(1-) > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > organooxygen compound > sphingolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > glycohexaosylceramide > monosialyl-gb5(1-) > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > liposaccharide > glycolipid > glycosphingolipid > globoside > monosialyl-gb5(1-) > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > liposaccharide > glycolipid > glycosphingolipid > globoside > monosialyl-gb5(1-) > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > glycosphingolipid > globoside > monosialyl-gb5(1-) > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > glycosphingolipid > globoside > monosialyl-gb5(1-) > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > organooxygen compound > sphingolipid > glycosphingolipid > globoside > monosialyl-gb5(1-) > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)

Preferred term

alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)  

Type

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

charge

  • -1

formula

  • C62H107N3O37R

mass

  • 1486.513

monoisotopicmass

  • 1485.65834

smiles

  • [C@H]([C@@H]([C@@H](CCCCCCCCCCCCCC)O)O)(NC(=O)*)CO[C@@H]1O[C@@H]([C@@H](O[C@@H]2O[C@@H]([C@H](O[C@@H]3[C@@H]([C@@H](O[C@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O[C@H]5[C@@H]([C@@H](O[C@]6(O[C@@]([C@@H]([C@H](C6)O)NC(C)=O)([H])[C@@H]([C@@H](CO)O)O)C([O-])=O)[C@H]([C@@H](CO)O5)O)O)NC(C)=O)[C@H]([C@@H](CO)O3)O)O)[C@@H]([C@H]2O)O)CO)[C@@H]([C@H]1O)O)CO

subset

  • 2_STAR

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:141011

Download this concept: